DAWNRAYS - Trademark Details
Status: 709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Image for trademark with serial number 79085256
Serial Number
79085256
Registration Number
3976651
Word Mark
DAWNRAYS
Status
709 - Registration cancelled because registrant did not file an acceptable declaration under Section 71
Status Date
2021-12-31
Filing Date
2010-04-27
Registration Number
3976651
Registration Date
2011-06-14
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260121, 261121 - Circles that are totally or partially shaded. Rectangles that are completely or partially shaded.
Published for Opposition Date
2011-03-29
Law Office Assigned Location Code
L30
Employee Name
JUN, WON KYUNG WENDY
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the wording "DAWNRAYS". To the left of the wording is a design element of a circle superimposed over a shaded rectangle.
Goods and Services
Chemical preparations for pharmaceutical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations for injection for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Pharmaceutical preparations in tablet form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Raw material medicines for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chemico-pharmaceutical preparations for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Chemical preparations for medical purposes for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases; Prepared traditional Chinese medicines for the treatment of respiratory system diseases, digestive system diseases, liver diseases, cardio-vascular system diseases and nervous system diseases; Medicines for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases in humans; Medicines in capsule form for the treatment of the nervous system diseases, the immune system diseases, the cardio-vascular system diseases, the metabolic system diseases, the respiratory system diseases, the digestive system diseases, the circulatory system diseases, the urinary system diseases, the endocrine system diseases, the blood system diseases, skin disorders, gynecological diseases, ophthalmic diseases, mental disorders, inflammatory disorders, liver diseases, tumor and deficiency diseases
Pseudo Mark
DAWN RAYS
Pseudo Mark
DAWN RAYS
Translation of Words in Mark
The wording "DAWNRAYS" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
F - Section 71 - Cancelled
Class Status Date
2021-12-31
Primary Code
005
Correspondences
Name
Beyond Attorneys at Law
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1045553
International Registration Date
2010-04-27
International Publication Date
2010-08-26
International Renewal Date
2030-04-27
Auto Protection Date
2012-02-19
International Status
001 - Request for extension of protection established
International Status Date
2010-08-19
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2010-08-19SN ASSIGNED FOR SECT 66A APPL FROM IB
2010-08-20NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2010-08-20ASSIGNED TO EXAMINER
2010-08-22NON-FINAL ACTION WRITTEN
2010-08-23NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2010-08-23REFUSAL PROCESSED BY MPU
2010-08-24APPLICATION FILING RECEIPT MAILED
2010-08-24NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2010-09-19REFUSAL PROCESSED BY IB
2011-01-31TEAS RESPONSE TO OFFICE ACTION RECEIVED
2011-02-07ASSIGNED TO LIE
2011-02-15CORRESPONDENCE RECEIVED IN LAW OFFICE
2011-02-15TEAS/EMAIL CORRESPONDENCE ENTERED
2011-02-17APPROVED FOR PUB - PRINCIPAL REGISTER
2011-02-24LAW OFFICE PUBLICATION REVIEW COMPLETED
2011-03-09NOTICE OF PUBLICATION
2011-03-10NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2011-03-10NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2011-03-29PUBLISHED FOR OPPOSITION
2011-06-14REGISTERED-PRINCIPAL REGISTER
2011-09-14FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2011-09-27FINAL DISPOSITION PROCESSED
2011-09-27FINAL DISPOSITION NOTICE SENT TO IB
2013-02-26FINAL DECISION TRANSACTION PROCESSED BY IB
2016-09-20TEAS CHANGE OF CORRESPONDENCE RECEIVED
2016-09-20TEAS SECTION 71 RECEIVED
2017-03-06CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2017-03-09POST REGISTRATION ACTION MAILED - SEC.71
2017-03-21TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
2017-04-06REGISTERED-SEC.71 ACCEPTED
2017-04-07NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED
2020-04-17NEW REPRESENTATIVE AT IB RECEIVED
2020-05-14INTERNATIONAL REGISTRATION RENEWED
2021-12-31CANCELLED SECTION 71